References
- RaoofDPinedaRDry eye after laser in-situ keratomileusisSemin Ophthalmol2014295–635836225325861
- SolomonKDHolzerMPSandovalHPRefractive surgery survey 2001J Cataract Refract Surg200228234635511821220
- ShojaMRBesharatiMRDry eye after LASIK for myopia: incidence and risk factorsEur J Ophthalmol20071711617294376
- ChaoCGolebiowskiBStapletonFThe role of corneal innervation in LASIK-induced neuropathic dry eyeOcul Surf2014121324524439045
- BowerKSSiaRKRyanDSMinesMJDarttDAChronic dry eye in photorefractive keratectomy and laser in situ keratomileusis: manifestations, incidence, and predictive factorsJ Cataract Refract Surg201541122624263426796443
- LentonLMAlbietzJMEffect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusisJ Refract Surg1999152 SupplS227S23110202728
- AlbietzJMLentonLMMcLennanSGEarlMLA comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patientsCLAO J20022829610012054380
- AstakhovYSAstakhovSYLisochkinaABAssessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIKClin Ophthalmol201372289229724353401
- GomesJAAmankwahRPowell-RichardsADuaHSSodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitroBr J Ophthalmol200488682182515148219
- SheYLiJXiaoBEvaluation of a novel artificial tear in the prevention and treatment of dry eye in an animal modelJ Ocul Pharmacol Ther201531952553026322539
- SimmonsPAVehigeJGInvestigating the potential benefits of a new artificial tear formulation combining two polymersClin Ophthalmol2017111637164228979093
- CorralesRMLuoLHChangEYPflugfelderSCEffects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cellsCornea200827557457918520508
- SimmonsPALiuHCarlisle-WilcoxCVehigeJGEfficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trialClin Ophthalmol2015966567525931807
- SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
- ChenJJRaoKPflugfelderSCCorneal epithelial opacity in dysfunctional tear syndromeAm J Ophthalmol2009148337638219541283
- MillerKLWaltJGMinkDRMinimal clinically important difference for the Ocular Surface Disease IndexArch Ophthalmol201012819410120065224
- NettuneGRPflugfelderSCPost-LASIK tear dysfunction and dysesthesiaOcul Surf20108313514520712970
- De PaivaCSChenZKochDDThe incidence and risk factors for developing dry eye after myopic LASIKAm J Ophthalmol2006141343844516490488
- AlbietzJMLentonLMMcLennanSGChronic dry eye and regression after laser in situ keratomileusis for myopiaJ Cataract Refract Surg200430367568415050267
- HuangJCSunCCChangCKMaDHLinYFEffect of hinge position on corneal sensation and dry eye parameters after femtosecond laser-assisted LASIKJ Refract Surg201228962563122947290
- LiMZhaoJShenYComparison of dry eye and corneal sensitivity between small incision lenticule extraction and femtosecond LASIK for myopiaPLoS One2013810e7779724204971
- LindstromRLHardtenDRHoutmanDMSix-month results of hyperopic and astigmatic LASIK in eyes with primary and secondary hyperopiaTrans Am Ophthalmol Soc19999724126010703127
- AlbietzJMLentonLMMcLennanSGEffect of laser in situ keratomileusis for hyperopia on tear film and ocular surfaceJ Refract Surg200218211312311934197
- BattatLMacriADursunDPflugfelderSCEffects of laser in situ keratomileusis on tear production, clearance, and the ocular surfaceOphthalmology200110871230123511425680
- PeachRJHollenbaughDStamenkovicIAruffoAIdentification of hyaluronic acid binding sites in the extracellular domain of CD44J Cell Biol199312212572648314845
- MackayCRTerpeHJStauderRMarstonWLStarkHGünthertUExpression and modulation of CD44 variant isoforms in humansJ Cell Biol19941241–271827507492
- BrignoleFPisellaPJDupasBBaeyensVBaudouinCEfficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitisGraefes Arch Clin Exp Ophthalmol2005243653153815965673
- LernerLESchwartzDMHwangDGHowesELSternRHyaluronan and CD44 in the human cornea and limbal conjunctivaExp Eye Res19986744814849820796
- AlbietzJMMcLennanSGLentonLMOcular surface management of photorefractive keratectomy and laser in situ keratomileusisJ Refract Surg200319663664414640428
- RodriguezAERodriguez-PratsJLHamdiIMGalalAAwadallaMAlioJLComparison of goblet cell density after femtosecond laser and mechanical microkeratome in LASIKInvest Ophthalmol Vis Sci20074862570257517525186
- RyanDSBowerKSSiaRKGoblet cell response after photorefractive keratectomy and laser in situ keratomileusisJ Cataract Refract Surg20164281181118927531295
- BaudouinCAragonaPMessmerEMRole of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meetingOcul Surf201311424625824112228
- PflugfelderSCCorralesRMde PaivaCST helper cytokines in dry eye diseaseExp Eye Res201311711812524012834
- StevensonWChauhanSKDanaRDry eye disease: an immune-mediated ocular surface disorderArch Ophthalmol201213019010022232476
- TodaIIdeTFukumotoTIchihashiYTsubotaKCombination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusisAm J Ophthalmol20141573616.e1622.e124528935
- Mateo OrobiaAJCasas PascualPCristobal BescosJAEffects of 3% trehalose as an adjuvant treatment after LASIKClin Ophthalmol20171134735328243058